Opp - a Universal Mental Health Promoting Mobile Application for Adolescents
NCT ID: NCT05211713
Last Updated: 2023-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
700 participants
INTERVENTIONAL
2022-08-01
2030-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
NettOpp: The Development and Evaluation of an App-based Selective Intervention for Adolescents Exposed to Cyberbullying
NCT04176666
Mind Power - A CBT Based Program for Adolescents
NCT03647826
The Norwegian "iCanCope With Pain" App
NCT03551977
Universal Preventive Resilience Intervention to Improve and Promote Mental Health for Teenagers
NCT03951376
Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury
NCT07224165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To evaluate the mobile application two studies will be conducted: A user survey and an effectiveness study with a follow-up examination after about six weeks. The effectiveness study will be conducted as a randomized controlled trial with an intervention group and a waiting-list control group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group receiving Opp
The effectiveness study will be conducted as a randomized controlled trial with an intervention group and a waiting-list control group. Data will be collected at baseline (T1, pre intervention) and after about six weeks of intervention (T2, post intervention).
Opp
Opp is a universal mental health promoting mobile application for adolescents aged 13-25 years.
Control group
The waiting list control group will receive the intervention after study completion.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Opp
Opp is a universal mental health promoting mobile application for adolescents aged 13-25 years.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
13 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Dam Foundation
OTHER
Norwegian Council for Mental Health
OTHER
Norwegian Directorate of Health
OTHER_GOV
University of Tromso
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henriette Kyrrestad, PhD
Role: PRINCIPAL_INVESTIGATOR
UiT The Arctic University of Norway
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UiT The Arctic University of Norway
Tromsø, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kaiser S, Rye M, Jakobsen R, Martinussen M, Hogsdal H, Kyrrestad H. A Universal Mental Health-Promoting Mobile App for Adolescents: Protocol for a Cluster Randomized Controlled Trial. JMIR Res Protoc. 2023 Jan 11;12:e42119. doi: 10.2196/42119.
Related Links
Access external resources that provide additional context or updates about the study.
Homepage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
279207
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.